alzheimer039s
The risks of developing many neurodegenerative diseases, including Alzheimer’s disease and amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig’s disease, increase significantly with age. However, there have been very few significant technological advances in treating these devastating diseases over the last few decades. The Search For Effective Treatments For Neurodegenerative DiseasesResearchers continue to search for life-altering treatments for neurodegenerative diseases that will lead to significantly improved patient outcomes. In ALS, the ultimate goals of treatment include s...
ValueWalk
Over the years, researchers have learned that chronic inflammation may be to blame in an increasing number of illnesses that were not originally thought to be inflammatory. Of course, inflammation has been implicated in many forms of arthritis and autoimmune diseases. Thus, targeting inflammation is becoming an even bigger and bigger market opportunity for biotech companies. According to one estimate, the global anti-inflammatory therapeutics market was worth $99.6 billion in 2021 and is expected to reach $127.5 billion by 2030 – a compound annual growth rate of 4.5% between 2022 and 2030. Tar...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら